No substitutes available
Inclusive of all taxes
1 prefilled syringe(s) of 0.8ml
Plamumab 40mg Injection is a biologic medication that contains the active ingredient Adalimumab, a monoclonal antibody designed to target and neutralize tumor necrosis factor-alpha (TNF-α), a substance in the body that causes inflammation. It is primarily used in the management of several chronic autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. By blocking TNF-α, Adlumab helps reduce inflammation, pain, swelling, and further joint or tissue damage associated with these conditions.
Plamumab 40mg Injection offers a more affordable treatment option without compromising efficacy or safety. The injection is typically administered subcutaneously every two weeks, although dosage frequency may vary based on the specific condition being treated and the patient’s clinical response.
This medication must be used under the supervision of a healthcare professional, and patients are usually monitored regularly for infections, allergic reactions, or changes in blood parameters. Plamumab 40mg Injection has significantly improved the quality of life for many individuals with autoimmune disorders by effectively managing symptoms and slowing disease progression.
Plamumab 40mg Injection (Adalimumab) may cause side effects, though not everyone gets them. Common ones include injection site pain, headache, nausea, fatigue, and mild infections like sore throat or sinusitis. Serious side effects such as severe infections, allergic reactions, liver issues, and changes in blood cell counts may also occur. As it weakens the immune system, Adlumab can increase infection risk and, rarely, certain cancers. Regular medical monitoring is important. Report symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin to your doctor immediately.
Helps reduce joint pain, swelling, and stiffness in adults with this autoimmune joint disorder.
Used to relieve symptoms of this chronic inflammatory disease affecting the spine and large joints.
Manages joint and skin symptoms in patients with this form of arthritis associated with psoriasis.
Used in children over 2 years of age to control joint inflammation and pain.
Treats this skin condition characterized by red, scaly patches by reducing skin inflammation.
Helps control inflammation in the digestive tract, relieving symptoms like abdominal pain and diarrhea.
Manages inflammation in the colon and rectum, improving bowel symptoms.
Plamumab 40mg Injection contains Adalimumab, a specially designed protein known as a monoclonal antibody. It targets and binds to tumor necrosis factor-alpha (TNF-α) — a substance in the body that causes inflammation and plays a major role in autoimmune diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
By attaching to TNF-α, Adalimumab blocks its interaction with TNF receptors found on immune cells. This action stops the chain of events that leads to inflammation and reduces the number of immune cells moving into inflamed tissues.
As a result, Plamumab 40mg Injection helps to:
This targeted approach makes Plamumab 40mg Injection effective in managing long-term inflammatory conditions.
Side Effects of Plamumab 40mg Injection
Like all medications, Plamumab 40mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The typical adult dosage of this medication varies depending on the condition being treated. For rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, the recommended dose is 40 mg every other week. In some cases, especially for patients not receiving methotrexate, the dose may be increased to 40 mg once weekly if additional benefit is needed.
For adults with plaque psoriasis, treatment begins with an initial dose of 80 mg, given as two 40 mg injections on the same day. This is followed by 40 mg every other week, starting one week after the initial dose. This schedule helps achieve and maintain consistent therapeutic levels.
In Crohn’s disease and ulcerative colitis, the dosing starts with an induction regimen of 160 mg on Day 1 (administered as four 40 mg injections in one day or split over two days), followed by 80 mg on Day 15. The maintenance dose is 40 mg every other week, beginning on Day 29. Depending on the patient’s response, the dose may be adjusted to achieve optimal results.
For pediatric patients, such as those with juvenile idiopathic arthritis or pediatric Crohn’s disease, dosing is weight-based. A pediatric specialist must carefully determine the appropriate dosage and schedule to ensure safety and effectiveness in children.
Plamumab 40mg Injection can generally be used during breastfeeding. However, always inform your doctor if you are breastfeeding before starting treatment.
It is not known whether alcohol is safe while using Plamumab 40mg Injection. Consult your doctor for specific advice.
Patients with lung conditions should use Plamumab 40mg Injection carefully. Always inform your doctor about any existing lung problems.
Plamumab 40mg Injection may cause dizziness, spinning sensations, or vision disturbances. Avoid driving, cycling, or operating heavy machinery if these symptoms occur.
Do not use Plamumab 40mg Injection during pregnancy unless prescribed by your doctor. Inform your physician if you are pregnant, planning pregnancy, or suspect pregnancy. Effective contraception should be used during treatment and for at least 5 months after the last dose.
Plamumab is used to treat autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, and juvenile idiopathic arthritis. It works by blocking TNF-alpha, a protein responsible for inflammation.
It is given as a subcutaneous injection (under the skin), usually once every two weeks, depending on your condition. It should be administered by a healthcare professional or someone trained to inject at home.
Yes, Plamumab is not recommended for people with severe liver problems, as it can further impair liver function. Always inform your doctor about any existing liver conditions before starting this medicine.Yes, after proper training by your doctor or nurse, you can inject Adlumab at home. Always follow the instructions on storage, preparation, and injection sites.
If you miss a dose, take it as soon as you remember. Then continue your next dose as scheduled. Do not take two doses at once to make up for a missed dose.
Common side effects include injection site pain, headache, fatigue, nausea, skin rash, and mild respiratory infections. Serious infections may also occur, so report any unusual symptoms to your doctor.
Use during pregnancy or breastfeeding should only be done under a doctor’s supervision. Discuss risks and benefits with your healthcare provider.
Avoid live vaccines while using Plamumab. Inform your doctor about any vaccinations you need before starting treatment.
| Active ingredient | Adalimumab |
| Pharmacologic class | Monoclonal antibody (mAb) |
| Medication category | Antirheumatic agent |
| Dosage forms | Injection |
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Plamumab 40mg Injection is a biologic medication that contains the active ingredient Adalimumab, a monoclonal antibody designed to target and neutralize tumor necrosis factor-alpha (TNF-α), a substance in the body that causes inflammation. It is primarily used in the management of several chronic autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. By blocking TNF-α, Adlumab helps reduce inflammation, pain, swelling, and further joint or tissue damage associated with these conditions.
Plamumab 40mg Injection offers a more affordable treatment option without compromising efficacy or safety. The injection is typically administered subcutaneously every two weeks, although dosage frequency may vary based on the specific condition being treated and the patient’s clinical response.
This medication must be used under the supervision of a healthcare professional, and patients are usually monitored regularly for infections, allergic reactions, or changes in blood parameters. Plamumab 40mg Injection has significantly improved the quality of life for many individuals with autoimmune disorders by effectively managing symptoms and slowing disease progression.
Plamumab 40mg Injection (Adalimumab) may cause side effects, though not everyone gets them. Common ones include injection site pain, headache, nausea, fatigue, and mild infections like sore throat or sinusitis. Serious side effects such as severe infections, allergic reactions, liver issues, and changes in blood cell counts may also occur. As it weakens the immune system, Adlumab can increase infection risk and, rarely, certain cancers. Regular medical monitoring is important. Report symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin to your doctor immediately.
Helps reduce joint pain, swelling, and stiffness in adults with this autoimmune joint disorder.
Used to relieve symptoms of this chronic inflammatory disease affecting the spine and large joints.
Manages joint and skin symptoms in patients with this form of arthritis associated with psoriasis.
Used in children over 2 years of age to control joint inflammation and pain.
Treats this skin condition characterized by red, scaly patches by reducing skin inflammation.
Helps control inflammation in the digestive tract, relieving symptoms like abdominal pain and diarrhea.
Manages inflammation in the colon and rectum, improving bowel symptoms.
Plamumab 40mg Injection contains Adalimumab, a specially designed protein known as a monoclonal antibody. It targets and binds to tumor necrosis factor-alpha (TNF-α) — a substance in the body that causes inflammation and plays a major role in autoimmune diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
By attaching to TNF-α, Adalimumab blocks its interaction with TNF receptors found on immune cells. This action stops the chain of events that leads to inflammation and reduces the number of immune cells moving into inflamed tissues.
As a result, Plamumab 40mg Injection helps to:
This targeted approach makes Plamumab 40mg Injection effective in managing long-term inflammatory conditions.
Side Effects of Plamumab 40mg Injection
Like all medications, Plamumab 40mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The typical adult dosage of this medication varies depending on the condition being treated. For rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, the recommended dose is 40 mg every other week. In some cases, especially for patients not receiving methotrexate, the dose may be increased to 40 mg once weekly if additional benefit is needed.
For adults with plaque psoriasis, treatment begins with an initial dose of 80 mg, given as two 40 mg injections on the same day. This is followed by 40 mg every other week, starting one week after the initial dose. This schedule helps achieve and maintain consistent therapeutic levels.
In Crohn’s disease and ulcerative colitis, the dosing starts with an induction regimen of 160 mg on Day 1 (administered as four 40 mg injections in one day or split over two days), followed by 80 mg on Day 15. The maintenance dose is 40 mg every other week, beginning on Day 29. Depending on the patient’s response, the dose may be adjusted to achieve optimal results.
For pediatric patients, such as those with juvenile idiopathic arthritis or pediatric Crohn’s disease, dosing is weight-based. A pediatric specialist must carefully determine the appropriate dosage and schedule to ensure safety and effectiveness in children.
Plamumab 40mg Injection can generally be used during breastfeeding. However, always inform your doctor if you are breastfeeding before starting treatment.
It is not known whether alcohol is safe while using Plamumab 40mg Injection. Consult your doctor for specific advice.
Patients with lung conditions should use Plamumab 40mg Injection carefully. Always inform your doctor about any existing lung problems.
Plamumab 40mg Injection may cause dizziness, spinning sensations, or vision disturbances. Avoid driving, cycling, or operating heavy machinery if these symptoms occur.
Do not use Plamumab 40mg Injection during pregnancy unless prescribed by your doctor. Inform your physician if you are pregnant, planning pregnancy, or suspect pregnancy. Effective contraception should be used during treatment and for at least 5 months after the last dose.
Plamumab is used to treat autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, and juvenile idiopathic arthritis. It works by blocking TNF-alpha, a protein responsible for inflammation.
It is given as a subcutaneous injection (under the skin), usually once every two weeks, depending on your condition. It should be administered by a healthcare professional or someone trained to inject at home.
Yes, Plamumab is not recommended for people with severe liver problems, as it can further impair liver function. Always inform your doctor about any existing liver conditions before starting this medicine.Yes, after proper training by your doctor or nurse, you can inject Adlumab at home. Always follow the instructions on storage, preparation, and injection sites.
If you miss a dose, take it as soon as you remember. Then continue your next dose as scheduled. Do not take two doses at once to make up for a missed dose.
Common side effects include injection site pain, headache, fatigue, nausea, skin rash, and mild respiratory infections. Serious infections may also occur, so report any unusual symptoms to your doctor.
Use during pregnancy or breastfeeding should only be done under a doctor’s supervision. Discuss risks and benefits with your healthcare provider.
Avoid live vaccines while using Plamumab. Inform your doctor about any vaccinations you need before starting treatment.
| Active ingredient | Adalimumab |
| Pharmacologic class | Monoclonal antibody (mAb) |
| Medication category | Antirheumatic agent |
| Dosage forms | Injection |
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
